Novo Nordisk A/S (NVO)

Novo Nordisk Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 9, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	297,785	384,855	461,550	304,426	256,201	162,142
Market Cap Growth	-46.87%	-16.62%	51.61%	18.82%	58.01%	18.73%
Enterprise Value	309,437	382,368	458,427	302,773	252,890	158,629
Last Close Price	65.77	85.00	101.44	65.75	53.85	33.13
PE Ratio	19.33	27.45	37.19	38.16	35.07	23.41
PS Ratio	6.78	9.55	13.40	11.97	11.90	7.77
PB Ratio	14.84	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	70.48	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	24.96	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	15.66	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	7.05	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	13.75	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	14.55	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	25.93	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.86	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.76	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.50	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.77	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.22	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.54	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.74	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	88.11%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	23.29%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	47.91%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	58.00%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	5.09%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	4.01%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	2.45%	1.86%	1.37%	1.35%	1.48%	2.26%
Payout Ratio	47.38%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.60%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	3.06%	2.57%	2.47%	2.69%	3.05%	3.88%

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q